<DOC>
	<DOCNO>NCT01345058</DOCNO>
	<brief_summary>This study determine whether combination low dose lacosamide levetiracetam effective high dose levetiracetam patient fail low dose levetiracetam .</brief_summary>
	<brief_title>Add Lacosamide Versus High Dose Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>1 . Adults age 18 old 2 . Determined least two partial seizure epilepsy specialist , single partial seizure clinical and/or laboratory evidence high seizure recurrence risk 3 . Monotherapy levetiracetam less equal 1500mg/day least two week 4 . Breakthrough seizure stable dose ( &gt; 5 day ) levetiracetam monotherapy regimen , due provocative factor ( e.g . hypoglycemia , head trauma , miss medication ) 1 . Clinical suspicion nonepileptic psychogenic seizure idiopathic generalize epilepsy 2 . Pregnant , childbearing age use contraception , breast feeding 3 . Medical contraindication add lacosamide 4 . History AED polytherapy 5 . Presence vagus nerve stimulator 6 . Creatinine clearance less 50mL/min 7 . Blood pressure instability : pulse &lt; 50 &gt; 100 , SBP &lt; 50 &gt; 180 , clinically significant EKG abnormality 8 . History significant drug rash anaphylactic reaction antiepileptic drug 9 . Patients progressive lesion ( e.g . brain tumor )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>antiepileptic drug</keyword>
	<keyword>polytherapy</keyword>
</DOC>